Study of ONO-8539 in Patients With Overactive Bladder

NCT00876421 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

435

Enrollment

INDUSTRY

Sponsor class

Conditions

Overactive Bladder

Interventions

DRUG: Placebo
DRUG: Tolterodine
DRUG: ONO-8539
DRUG: ONO-8539
DRUG: ONO-8539

Sponsor

Ono Pharmaceutical Co., Ltd.